|
11.00 |
Registration & Coffee |
All |
13.00 |
Introduction to Conference |
M. Gossop (UK) |
Session 1
13.15 - 15.30
Substance Misuse & Society
Chair: M. Gossop (UK) |
13.15 |
Keynote address: Drugs do harm |
J. Strang (UK) |
| |
14.00 |
Accidental Deaths and Substance Related Mortality |
A. Uhl (AT) |
| |
14.25 |
Cannabis in Europe - Recent Trends in Use & Problems |
P. Griffiths
L. Montanari
J. Vincente (PT) |
| |
14.55 |
Outpatient Treatment of Alcohol & Drug Addicted Physicians: Case Presentation & Clinical Considerations |
A. Cavailoa (USA) |
| |
15.20 |
Discussion |
All |
16.00 - 18.00
Substitution Treatment for Opioid Addiction
Chair: M. Farrell (UK) |
| |
16.00 |
US Trials and Field Experience with Buprenorphine-Naloxone |
L. Amass (USA) |
| |
16.30 |
A randomised trial of supervised versus unsupervised buprenorphine-naloxone in the treatment of opioid dependence |
J. Bell (AUS) |
| |
17.00 |
The Finnish Experience: Transferring from Buprenorphine to the Buprenorphone/Naloxone Combination |
K Simojoki (FIN) |
| |
17.30 |
The UK Scene - Do We Need Suboxone? |
N. Wright (UK) |
Session 2
18.00 - 18.30
Late Breaking News, Case Studies, Culture & History
Chair: M. Gossop (UK) |
| |
18.00 |
Incidence of Herion use has Declined Dramatically on Zurich, Switzerland |
C. Nordt (CH)
R. Stohler (CH) |
| |
18.15 |
TBA |
TBA |
|
|
